Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...

The outspoken longevity scientist David Sinclair has been predicting that one day, you’ll go to the doctor and get a ...

The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...

Antonio Regalado —Will Douglas Heaven At SXSW London last week, I gave a talk called “Five things you need to know about AI,” ...

NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...

The raise signals a pattern among crypto executives channeling wealth into adjacent technology sectors. Armstrong has already ...

Zhou’s study, "TBX20 improves contractility and mitochondrial function during direct human cardiac reprogramming," was recently published in Circulation. The most common cause of death worldwide is ...